5HVF
Crystal Structure of Thrombin-activatable Fibrinolysis Inhibitor in Complex with an Inhibitory Nanobody (VHH-i83)
5HVF の概要
エントリーDOI | 10.2210/pdb5hvf/pdb |
関連するPDBエントリー | 5HVG 5HVH |
分子名称 | Carboxypeptidase B2, VHH-i83, alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (7 entities in total) |
機能のキーワード | procarboxypeptidase u, thrombin-activatable fibrinolysis inhibitor, tafi, procarboxypeptidase r, plasma procarboxypeptidase b, nanobody, antibody fragment, protein complex, hydrolase/hydrolase inhibitor, hydrolase, hydrolase-hydrolase inhibitor complex |
由来する生物種 | Homo sapiens (Human) 詳細 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 60624.13 |
構造登録者 | Zhou, X.,Weeks, S.D.,Strelkov, S.V.,Declerck, P.J. (登録日: 2016-01-28, 公開日: 2016-06-22, 最終更新日: 2024-01-10) |
主引用文献 | Zhou, X.,Weeks, S.D.,Ameloot, P.,Callewaert, N.,Strelkov, S.V.,Declerck, P.J. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity. J.Thromb.Haemost., 14:1629-1638, 2016 Cited by PubMed: 27279497DOI: 10.1111/jth.13381 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.85 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード